These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20932268)

  • 41. Emergent cardiovascular risk factor: homocysteine.
    Warren CJ
    Prog Cardiovasc Nurs; 2002; 17(1):35-41. PubMed ID: 11872979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Homocysteine-betaine interactions in a murine model of 5,10-methylenetetrahydrofolate reductase deficiency.
    Schwahn BC; Chen Z; Laryea MD; Wendel U; Lussier-Cacan S; Genest J; Mar MH; Zeisel SH; Castro C; Garrow T; Rozen R
    FASEB J; 2003 Mar; 17(3):512-4. PubMed ID: 12551843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Homocysteine is not so paradoxical.
    Klevay LM
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):e160; author reply e161. PubMed ID: 18799792
    [No Abstract]   [Full Text] [Related]  

  • 44. Hyperhomocysteinemia: an additional cardiovascular risk factor.
    Fanapour PC; Yug B; Kochar MS
    WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients.
    Mallamaci F; Zoccali C; Tripepi G; Fermo I; Benedetto FA; Cataliotti A; Bellanuova I; Malatino LS; Soldarini A;
    Kidney Int; 2002 Feb; 61(2):609-14. PubMed ID: 11849403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Homocysteine metabolism and its role in pathology].
    Pentiuk OO; Lutsiuk MB; Andrushko II; Postovitenko KP
    Ukr Biokhim Zh (1999); 2003; 75(1):5-17. PubMed ID: 14574730
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low diagnostic value of fasting and post-methionine load homocysteine tests. A study in Dutch subjects with homocysteine test indications.
    Fokkema MR; Dijck-Brouwer DA; van Doormaal JJ; Reijngoud DJ; Muskiet FA
    Clin Chim Acta; 2003 May; 331(1-2):153-7. PubMed ID: 12691876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human Health.
    Škovierová H; Vidomanová E; Mahmood S; Sopková J; Drgová A; Červeňová T; Halašová E; Lehotský J
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775595
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Homocysteine and pro-inflammatory cytokine concentrations in acute heart disease.
    Gokkusu C; Tulubas F; Unlucerci Y; Ozkok E; Umman B; Aydin M
    Cytokine; 2010 Apr; 50(1):15-8. PubMed ID: 20129796
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Disturbances of homocysteine metabolism as a risk factor of cardiovascular diseases development: effect on prognosis and possibilities of correction with drugs].
    Shakhmatova OO; Komarov AL; Panchenko EP
    Kardiologiia; 2010; 50(1):42-50. PubMed ID: 20144157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models.
    Wilson KM; Lentz SR
    Semin Vasc Med; 2005 May; 5(2):163-71. PubMed ID: 16047268
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective role of mast cells in homocysteine-induced cardiac remodeling.
    Joseph J; Kennedy RH; Devi S; Wang J; Joseph L; Hauer-Jensen M
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2541-5. PubMed ID: 15591099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ADMA and hyperhomocysteinemia.
    Dayal S; Lentz SR
    Vasc Med; 2005 Jul; 10 Suppl 1():S27-33. PubMed ID: 16444866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hyperhomocysteinemia and cardiometabolic risk].
    Vannucchi H; Melo SS
    Arq Bras Endocrinol Metabol; 2009 Jul; 53(5):540-9. PubMed ID: 19768245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hyperhomocysteinemia and lower extremity wounds.
    Schwartzfarb EM; Romanelli P
    Int J Low Extrem Wounds; 2008 Sep; 7(3):126-36. PubMed ID: 18757388
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyperhomocysteinemia and end-stage renal disease: determinants and association with cardiovascular disease in Tunisian patients.
    Fellah H; Feki M; Hsairi M; Sanhaji H; Kaabachi N; Ben Abdallah T; Massy ZA; Ben Maiz H; Lacour B; Mebazaa A
    Clin Chem Lab Med; 2003 May; 41(5):675-80. PubMed ID: 12812266
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Homocysteine: is it a clinically important cardiovascular risk factor?
    Lentz SR; Haynes WG
    Cleve Clin J Med; 2004 Sep; 71(9):729-34. PubMed ID: 15478704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study of the Inflammatory Mechanisms in Hyperhomocysteinemia on Large-Artery Atherosclerosis Based on Hypersensitive C-Reactive Protein-A Study from Southern China.
    Cao L; Guo Y; Zhu Z
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1816-1823. PubMed ID: 31080137
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Homocysteine in uremia.
    Perna AF; Ingrosso D; Lombardi C; Cesare CM; Acantora F; Satta E; De Santo NG
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S123-6. PubMed ID: 12612968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Homocysteine as a risk factor for atherosclerosis.
    Temple ME; Luzier AB; Kazierad DJ
    Ann Pharmacother; 2000 Jan; 34(1):57-65. PubMed ID: 10669187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.